发明名称 Liver selective drug therapy
摘要 A method of pharmaceutical therapy comprising administering at least one pharmaceutical, complementary medicine, or herbal product, orally at a dose sufficient to provide a clinically effective blood level in the portal vein and less than that required to provide a clinically effective blood level in the peripheral circulation to thereby provide a dose-delivery rate having a selective clinical effect in the liver.
申请公布号 US2008242732(A1) 申请公布日期 2008.10.02
申请号 US20070819279 申请日期 2007.06.26
申请人 SMITH HOWARD J 发明人 SMITH HOWARD J.
分类号 A61K9/16;A61K31/135;A61K9/22;A61K31/138;A61K31/19;A61K31/22;A61K31/351;A61K31/366;A61K31/40;A61K31/56;A61K31/573;A61P1/16;A61P3/06;A61P9/12;A61P31/12 主分类号 A61K9/16
代理机构 代理人
主权项
地址